Thrombocytopenia in the Intensive Care Unit



Thrombocytopenia in the Intensive Care Unit


Warren Isakow



Thrombocytopenia is a very common occurrence in the intensive care unit (ICU), occurring in as many as 60% of patients. The normal platelet count ranges between 150,000 and 450,000/µL. In the ICU, it is important to recognize that the absolute platelet count is important, but trends in the platelet count, specifically a decline by more than one-half, may be evidence of a serious clinical problem such as heparin-induced thrombocytopenia (HIT), which requires urgent attention. A systematic approach to the diagnosis allows for the common causes to be detected early and enables rational use of platelet transfusions (Algorithm 62.1). Platelet survival in the circulation is approximately 7 to 10 days, and one-third of the platelets are sequestered in the spleen under normal circumstances.

Recognition of thrombocytopenia normally occurs after a complete blood count is drawn, but it is important to remember that mucocutaneous bleeding is a classic sign of thrombocytopenia. Bleeding from thrombocytopenia normally occurs only once the platelet count is <50,000/µL in postsurgical patients; spontaneous bleeding can occur with counts <5000/µL. The diagnostic approach starts with a thorough history and physical examination, followed by examination of the peripheral smear. A pathophysiologic approach to thrombocytopenia enables all common causes to be rapidly screened for and facilitates recognition of potential causes (Table 62.1). Careful attention should be paid to prescription and over-the-counter drugs (Table 62.2).

The common causes of thrombocytopenia in an ICU setting are as follows:



  • Drug-induced (heparin, H2-receptor blockers, GP2b3a inhibitors, antibiotics, alcohol)


  • Sepsis


  • Massive bleeding


  • Thrombocytopenia with microangiopathic hemolytic anemia (thrombocytopenic thrombotic purpura [TTP], hemolytic uremic syndrome [HUS], disseminated intravascular coagulation [DIC]).

Clinical recognition of the cause is vital, as the therapies differ considerably depending on the etiology. For example, a patient with thrombocytopenia secondary to bleeding should be treated with platelets compared with a patient with TTP/HUS, in whom platelet transfusion is generally contraindicated. A few common conditions will be discussed, and readers are encouraged to refer to Suggested Reading for further details.







ALGORITHM 62.1 Diagnostic Algorithm for Thrombocytopenia









TABLE 62.1 Pathophysiologic Classification of Thrombocytopenia







































































































Decreased production


Increased destruction


Increased sequestration


Aplastic anemia


Immunologic


Hypersplenism from any cause:


Hematologic malignancies



ITP



Cirrhosis



Lymphoma



Heparin-induced (HIT)



Portal hypertension



Leukemia



Drug-induced (see Table 62.2)



Congestive heart failure



Myelodysplasia



HIV



Hematologic malignancies


Metastatic malignancy



Autoimmune disease



Lipid storage disorders


Nutritional (vitamin B12 and folate)



Infectious


Drugs (see Table 62.2)


Posttransfusion purpura


Chemotherapy and radiation


Antiphospholipid antibody syndrome


Alcohol


Nonimmunologic


Viral infections



DIC



HIV



HUS/TTP



Mumps



HELLP syndrome



Parvovirus



Preeclampsia/eclampsia



Varicella



Malignant HTN



Rubella



Sepsis



Epstein-Barr



Cardiac valves (prosthetic endocarditis)



Hepatitis C



Burns





Massive bleeding


HIV, human immunodeficiency virus; ITP, immune thrombocytopenic purpura; HIT, heparin-induced thrombocytopenia; DIC, disseminated intravascular coagulation; HUS, hemolytic uremic syndrome; TTP, thrombotic thrombocytopenic purpura; HELLP, hemolysis, elevated liver enzyme levels and a low platelet count; HTN, hypertension.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 20, 2016 | Posted by in CRITICAL CARE | Comments Off on Thrombocytopenia in the Intensive Care Unit

Full access? Get Clinical Tree

Get Clinical Tree app for offline access